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Abstract
BACKGROUND: Patients presenting with diabetic ketoacidosis (DKA) are hypovolemic, hyperglycemic,
and acidotic. First line therapy is administration of resuscitation crystalloid fluids to increase systemic pressure
for maintenance of tissue perfusion. Volume repletion can be measured by monitoring several physiological
indicators including mean arterial pressure (MAP) and urine output (UO), where an increase of both indicate
an improvement in volume status. The crystalloid fluid recommended by the American Diabetes Association
(ADA) is normal saline (NS) because it has a track record of being a safe option. However, administration of
NS can induce hyperchloremic metabolic acidosis (HMA) in many patients receiving it for rapid and large
volume fluid replacement in a spectrum of circumstances and in most who receive it for DKA. An alternate
crystalloid, Plasma-Lyte, is a balanced electrolyte solution (BES) with composition similarities to plasma,
therefore it has less potential to cause biochemical changes in electrolytes, such as hyperchloremic acidosis. In
this study evidence for use of a Plasma-Lyte (PL) versus NS was evaluated to determine if Plasma-Lyte is a
better option for fluid resuscitation of DKA.
METHODS: A thorough search was conducted in three separate databases, Medscape, CINAHL, and Web of
Science. Search terms included: diabetic ketoacidosis, Plasma-Lyte, normal saline, hyperchloremic acidosis, and
fluid resuscitation. Eligibility criteria were limited to adult DKA patients receiving NS or PL fluid therapy. Data
quality was assessed using the GRADE system.
RESULTS: Two studies were determined eligible. Results were significant for hyperchloremia in groups
receiving NS in both studies. In one study, Chua et al showed significant increases (p = < 0.01) in bicarbonate
in the PL group at two intervals between 4 and 12 hours after fluid therapy initiation. Mahler et al found only
a relative difference (p < .02) in bicarbonate between groups. Chua et al also found the mean arterial blood
pressure at 2-4 hours and urine output at 4-6 to be higher in Plasma-Lyte therapy compared with normal
saline.
CONCLUSION: DKA patients treated with Plasma-Lyte had lower serum chloride concentrations and
higher serum bicarbonate concentrations compared with NS. Inference can also be made for some benefit in
time of recovery with more rapidly improved MAP and UO in DKA with a PL versus NS.
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Abstract   
 
BACKGROUND:  Patients presenting with diabetic ketoacidosis (DKA) are hypovolemic, 
hyperglycemic, and acidotic.  First line therapy is administration of resuscitation crystalloid 
fluids to increase systemic pressure for maintenance of tissue perfusion.  Volume repletion can 
be measured by monitoring several physiological indicators including mean arterial pressure 
(MAP) and urine output (UO), where an increase of both indicate an improvement in volume 
status.  The crystalloid fluid recommended by the American Diabetes Association (ADA) is 
normal saline (NS) because it has a track record of being a safe option.  However, administration 
of NS can induce hyperchloremic metabolic acidosis (HMA) in many patients receiving it for 
rapid and large volume fluid replacement in a spectrum of circumstances and in most who 
receive it for DKA.  An alternate crystalloid, Plasma-Lyte, is a balanced electrolyte solution 
(BES) with composition similarities to plasma, therefore it has less potential to cause 
biochemical changes in electrolytes, such as hyperchloremic acidosis.  In this study evidence for 
use of a Plasma-Lyte (PL) versus NS was evaluated to determine if Plasma-Lyte is a better 
option for fluid resuscitation of DKA. 
 
METHODS:  A thorough search was conducted in three separate databases, Medscape, 
CINAHL, and Web of Science.  Search terms included: diabetic ketoacidosis, Plasma-Lyte, 
normal saline, hyperchloremic acidosis, and fluid resuscitation.  Eligibility criteria were limited 
to adult DKA patients receiving NS or PL fluid therapy.  Data quality was assessed using the 
GRADE system. 
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RESULTS:  Two studies were determined eligible.  Results were significant for hyperchloremia 
in groups receiving NS in both studies.  In one study, Chua et al15 showed significant increases 
(p = < 0.01) in bicarbonate in the PL group at two intervals between 4 and 12 hours after fluid 
therapy initiation.  Mahler et al14 found only a relative difference (p < .02) in bicarbonate 
between groups. Chua et al15 also found the mean arterial blood pressure at 2-4 hours and urine 
output at 4-6 to be higher in Plasma-Lyte therapy compared with normal saline.  
 
CONCLUSION: DKA patients treated with Plasma-Lyte had lower serum chloride 
concentrations and higher serum bicarbonate concentrations compared with NS.  Inference can 
also be made for some benefit in time of recovery with more rapidly improved MAP and UO in 
DKA with a PL versus NS.  
 
KEYWORDS:  Diabetic Ketoacidosis; PlasmaLyte; Balanced Electrolyte Solution; Normal 
Saline; Hyperchloremic Metabolic Acidosis; Fluid Resuscitation 
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Plasma-Lyte vs. Normal Saline: Preventing Hyperchloremic Acidosis in Fluid 
Resuscitation for Diabetic Ketoacidosis. 
 
BACKGROUND  
 
Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes mellitus (DM) 
and its mortality rate approaches 100% without treatment.1 DKA comprises 8 -29% of all 
hospital admitted diabetes cases2 and 30% of these are patients with first time diagnosis of 
diabetes.3  The mortality rate with DKA is now < 5%, according to United States Center for 
Disease Control (CDC) statistics.  The acuity and gravity of DKA make it a commonly treated 
condition in emergency medicine and intensive care units, with an increasing occurrence as we 
see a higher incidence of DM in the population.2 
Diabetic ketoacidosis is defined as a triad of hyperglycemia, ketosis, and acidosis. 
Hyperglycemic complications in DKA are predominantly due to a significant increase in hepatic 
gluconeogenesis causing glycosuria, osmotic diuresis, and dehydration.  Body fluid loss due to 
osmotic diuresis and hyperosmolar intracellular dehydration can be 5-10%, resulting in a 
reduction in systemic pressure and thus tissue perfusion.4,5 
Fluid replacement therapy with a crystalloid solution is first line in the treatment of DKA 
with the goal of increasing volume and improving tissue perfusion.  Also, it can reduce serum 
glucose up to 25% on its own.6  Insulin is a secondary treatment which should be withheld in 
hypotensive and/or hypokalemic patients.3  Current guidelines recommend NS as the 
replacement fluid of choice.  However, evidence shows rapid, high volume fluid volume 
replacement with NS can lead to hyperchloremic metabolic acidosis (HMA), with increased 
serum levels of chloride and decreased bicarbonate.  Significant increases in chloride levels and 
HMA have been shown in multiple uses of NS for fluid replacement, including intraabdominal 
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gynecological surgery,7 intra-operative fluid therapy,8 kidney replacement post-operative fluid 
therapy.9   
Alternative crystalloids, known as balanced electrolyte solutions (BES), are available.  
One such BES is the product Plasma-Lyte (PL).  Plasma-Lyte products contain organic acid 
buffers like acetate and gluconate, and are engineered to be physiologically similar to plasma.10 
They are more similar to body fluid composition than NS, making them less likely to lead to 
hyperchloremic metabolic acidosis (HMA) as with NS.10  In composition, NS has a higher 
chloride content than PL (154 mEq/L and 98 mEq/L respectively).  The evidence for safety in 
use of PL is lacking and NS has had a long term safety record as fluid therapy.  Also, the clinical 
significance of HMA is debatable with respect to changing patient outcomes, and may differ 
with the volume of fluid given over a period of time and across the spectrum of conditions 
requiring fluid resuscitation.  A study of ED patients treated with NS vs. PL for dehydration had 
no difference in outcome of acid-base status, but they did show a significant occurrence of lower 
pH values compared with PL and lactated Ringers.11  In the case of DKA, a secondary acidotic 
state, such as with NS induced HMA, may be impede an optimal recovery rate.  Patients 
presenting with DKA have an inherent initial chloremic acidosis with a decrease in bicarbonate 
followed by proximal tubule reabsorption of chloride.12  A solution which does not cause further 
derangements in physiological status may be the better option for treatment, and may be an even 
more important consideration with special populations of DKA patients, such as decreased renal 
function, pediatrics, and patients with various metabolic disorders.  The purpose of this study is 
to evaluate the quality of the current evidence for the use of a PL versus NS to prevent 
hyperchloremic metabolic acidosis in the setting of DKA. Should fluid recommendations favor 
the use of Plasma-Lyte over normal saline? 
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METHODS 
A thorough search was conducted in three separate databases including Medscape, 
CINAHL, and Web of Science.  Search terms included, but were not limited to: diabetic 
ketoacidosis, Plasma-Lyte, balanced electrolyte solution, normal saline, hyperchloremic 
acidosis, and fluid resuscitation.  Bibliographies were searched for additional literature.  Studies 
evaluating normal saline versus Plasma-Lyte for fluid resuscitation therapy in DKA patients 
were selected.  
Eligibility criteria were limited to human adults and English language.  Each study was 
assessed for bias, and screened for strengths and weaknesses.  Quality of the data from the two 
eligible studies included in this systematic review was assessed using the GRADE system (Table 
1).  
  
RESULTS 
A search for the terms Plasma-Lyte and diabetic ketoacidosis produced 2 results in 
Medscape , 1 in CINAHL, and 2 in Web of Science.  Use of alternate search word combinations 
provided results of 0-1, all of which were duplicates of the former.  After duplicates between 
databases were eliminated and each was reviewed for content and two eligible results were 
obtained which included DKA as the diagnosis for which the fluid replacement therapies in 
question, Plasma-Lyte and normal saline, were compared. 
The earlier of the two studies, Mahler et al,13 was a double blinded, randomized 
controlled trial with intent to treat.  The researchers compared the outcome of chloride and 
bicarbonate levels with separate use of the fluid replacement therapies Plasma-Lyte A and NS in 
a convenience sample of patients aged 18-65 with moderate to severe DKA admitted to the 
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Lousiana State University Health Sciences Center-Shreveport Emergency Department over 24 
months (2006-2008).  Eligibility criteria were described and excluded patients presenting with 
hyperosmolar hyperglycemic non-ketotic syndrome, hyperglycemia without signs of DKA, and 
those having received intervention of greater than 500 mL boluses of crystalloid solution or 
insulin boluses prior to study enrollment.  Also excluded were patients presenting with possible 
myocardial infarction, sepsis, respiratory failure, cerebral edema, or patients receiving less than 4 
hours of fluid therapy.  All participants were recruited from a single location and the subject 
sampling included 23 in the NS group and 22 in the PL group.  Patient demographics were 
balanced in all except for race, where 83% in the NS group and 68% in the PL group were 
African American.  Blinding was described as a block randomization method of 8 consecutive 
participants, and all subjects and providers were blinded to the randomization schedule and 
treatment.13 
A standardized resuscitation protocol was allotted in a 1:1 manner for 0.9% NS or 
Plasma-Lyte (Plasma-Lyte A 7.4; Baxter International, Deerfield, IL).  Patient water deficits and 
maintenance fluid requirements were calculated before receiving fluid therapy.  Blinded study 
fluids were provided by institution’s pharmacy.  A regular insulin drip was administered to all 
patients without boluses and use of sodium bicarbonate was avoided.  Resuscitation therapy was 
completed in either the emergency department or the medical intensive care unit, and was 
considered complete at a target anion gap at 12 mEq/L or below.13 
Data collection included baseline chemistry panels of serum sodium, potassium, chloride, 
bicarbonate, blood urea nitrogen, creatinine, glucose, and a calculated anion gap.  Chemistry 
panels were repeated every 2 hours throughout the study.  Statistical analysis used SPSS 11.0 
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(Chicago, IL) for Windows.  Serum chloride and bicarbonate data comparisons for NS and PL 
groups were calculated using student t tests.13 
 Results showed a significant increase in serum chloride (p = ≤ 0.001) and a relative 
decrease in bicarbonate concentrations (p = 0.02) in the NS group as shown in Table 2.  The 
difference in serum chloride was the most significant and outside of normal limits, or 
hyperchloremic, at 111 mEq/L, (serum chloride reference range for adults = 96-106 mEq/L) in 
the NS group.  The PL group serum chloride was within normal limits at 105 mEq/L.  Also 
interesting was the comparison of the baseline concentrations, where the chloride baseline was 
lower for the NS group.13 
In the second and more recent study, Chua et al,14 used biochemical and hemodynamic 
parameters to assess the efficacy and safety of NS compared to Plasma-Lyte 148 (PL) in fluid 
resuscitation of DKA.  The study design was a multicenter retrospective study of adult patients 
admitted to intensive care units (ICUs) in three separate tertiary hospital locations in Australia.  
Included were patients 16 years and older who received only or predominantly NS or PL for the 
first 12 hours of fluid replacement.  A set baseline of 0-2 hours from ED admission was meant to 
offset pre-admission fluid administration confounders.  Excluded were: 1) patients who had 
received more than 500 mL of a non-study crystalloid within 12 hours from baseline, 2) patients 
who had received more than 50 mEq of sodium bicarbonate and/or potassium acetate within 12 
hours from baseline, and 3) patients with end stage or advanced chronic kidney disease with an 
estimated glomerular filtration rate less than 30 mL/min/1.73 at baseline.14 
DKA resolution, the primary outcome, was measured by the following indicators: serum 
pH, bicarbonate levels, standard base excess (SBE), and strong ion gap (SIG).  The secondary 
outcomes included: 1) cumulative insulin requirement and glycemic control measured by 
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cumulative dose all given insulin, intravenous (IV) and subcutaneous, and duration of IV insulin 
administered over 24 hours, and 12 hours post-therapy glucose level reduction, 2) potassium 
balance over 24 hours, 3) mean arterial blood pressure (MAP) and heart rate over 24 hours, 4) 
cumulative urine output and serum creatinine decline over 24 hours, and 5) time spent in the 
intensive care unit for treatment.  There were 9 subjects in the PL group and 14 in the NS 
group.14 
Serum biochemistry and clinical indicator values were taken from timed intervals of 
therapy from baseline 2-4 hours, 4-6 hours, 6-12 hours, and 20-28 hours.  Serum bicarbonate 
levels were calculated using empiric formulas.  Statistical analysis comparing NS to PL groups 
compared serum biochemistries and clinical indicators with respect to baseline values.  A P 
value < .05 was used as a measure of significance.  Baseline characteristics were compared with 
obtained median values (interquartile ranges, IQRs) using Kruskal-Wallis for continuous 
variables and Fisher exact test for categorical variables.  Baseline differences in serum 
biochemistries were significant only for apparent strong ion difference (appSID) and SIG (p = < 
.05), which was higher in the NS group (SIG is calculated using appSID and effective SID).  The 
variables of age, sex, DKA precipitant, illness severity, and remaining serum biochemistries 
were not significantly different between groups at baseline.  Resolution of DKA was determined 
by SIG reduction over time.14 
Results showed that the change in serum bicarbonate levels was significant at the 4-6 
hour interval (p = < .01) and at the 6-12 hour interval (p = < .05) with a more rapid increase in 
levels for the PL group.  The change in chloride levels was significant between groups at all time 
intervals (p = < .01), with a steady lower chloride level in the PL group and an increasing rise in 
level in the NS group over time.  Also of significance were the secondary outcomes of mean 
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arterial blood pressure (MAP) at the 2-4 hour interval (p = < .05), and urine output (UO) at the 4-
6 hour interval.  Both were higher for the PL group.14 
 
DISCUSSION 
Evaluations comparing the use NS vs. PL in both Mahler et al13 and Chua et al14 illustrate 
evidence favoring the use of PL for preventing HMA in DKA patients.  Plasma-Lyte use has 
been shown to prevent hyperchloremic acidosis in fluid replacement therapy in DKA, as 
compared to normal saline, which induces it.  The clinical significance of hyperchloremia has yet 
to be determined, but the evidence from Chua et al14 shows PL may improve recovery of DKA 
with findings of a significantly more rapid increase in MAP and UO with PL fluid therapy, 
indicators of volume repletion.  It is also important to note there were no adverse effects from the 
use of PL in this study. 
Increasing systemic volume is priority and the induced hyperchloremic acidosis in use of 
NS is transient and has not been considered clinically significant except with cases of acute renal 
failure and extreme oliguria.3  In that regard, diabetes is often associated with end organ damage, 
especially with respect to kidney function.  As many as 30% of DKA cases, are associated with 
first time diagnosis15, and extent of end organ damage may be unknown in these patients, and 
will vary by population.  Considerations for beneficial application may be more important in 
special populations, for example, populations that are diagnosed in later stages of disease, 
including older populations, and African American men.  Data from the CDC shows African 
American men account for more hospital admissions for DKA and have a higher rate of DM 
associated end stage renal disease.    
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Although not included in these studies, the special population of diabetic pediatric 
patients may benefit greatly from use of PL over NS.  Currently guidelines recommend strict 
protocols16 in fluid resuscitation in pediatric DKA because of the risk of cerebral edema (CE) 
which has high a morbidity and mortality rate.  Sodium bicarbonate has been used as therapy for 
treating metabolic acidosis, however it has been shown to be ineffective therapy in pediatric 
DKA17 and has been associated with increased risk of CE in this population, and should be 
avoided.18  
The Mahler et al13 study had a small population, used a single location for recruitment, 
and had a potential for bias by use of a convenience population, thus limiting the precision and 
application of its findings.  The small population also may have contributed to the slight 
differences in baseline chloride between groups with a lower baseline chloride in the NS group. 
However, the fact that the NS group was lower at baseline than the PL group further supports the 
study’s outcomes of hyperchloremia prevention with PL.13 
Also, as addressed and described by Mahler et al,13 this study may not be generally 
applicable because of DKA diagnostic and monitoring protocol differences from that of the 
ADA.  The ADA protocol uses blood gases and pH values to determine mild, moderate, and 
severe DKA.  Blood gases and pH were not utilized in this study for defining DKA in subjects 
per institutional practice feasibility, thus limiting generalization to institutions using strict ADA 
protocol.13 
The Chua et al14 study had similar limitations with population size.  The small sample 
size may have been responsible for creating baseline characteristic imbalances, specifically with 
appSID and SIG for this study, which was the major contribution to downgrading the study 
quality.  As explained by the authors, the acid-base effects were rapidly apparent and strongly 
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significant despite this.  Conclusions of clinical data for the secondary outcomes of time in ICU, 
discharge from hospital, and survival are also not feasible with a small sample size.  Some of the 
data for recovery time at the later time intervals may also be imprecise because of the 
administration of mixed fluids in some patients beyond the 12th hour of resuscitation.14 
 Limitations of this systematic review include those of the studies themselves being of 
moderate and low quality for reasons described above (Table 1), and also some of the differences 
between each study.  Though both studies used Plasma-Lyte as a comparison to NS, the 
formulations of the PL fluids had a variation in the solution pH, but were otherwise equal in 
formulation. Plasma-Lyte 148 has a pH of 5.5 (4.0-8.0) and the pH of Plama-Lyte A is 7.4 (6.5 to 
8.0). The significance of this cannot be determined, but may alter the precision of the results. 
 For the purpose of this review there were no flaws in study design, no significant 
limitations, and no inconsistencies found in either study.  Though the baseline characteristics 
were different between groups in Chua et al,14 the specific differences were not the parameters of 
interest for this review.  Imprecision was the greatest limitation for each, and this can mostly be 
attributed to population size.   
Improvement and maintenance of tissue perfusion by increasing systemic volume is the 
goal of fluid replacement.  A more rapid improvement without side effects would appear to be 
the better option.  Overall, the effects were strong in both studies, suggesting use of Plasma-Lyte 
is a safe and better option for biochemical stability in DKA when compared to the currently 
recommended use of NS.  
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CONCLUSION 
DKA patients treated with Plasma-Lyte had lower serum chloride concentrations and higher 
serum bicarbonate concentrations compared with NS.  Inference can also be made for some 
benefit in time of recovery with more rapidly improved MAP and UO in DKA with PL versus 
NS.  Overall, Plasma-Lyte had better biochemical profiles for chloride and bicarbonate. The 
clinical significance of this will require further investigation, but these studies support the value 
of such inquiries.  
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Table 1. Characteristics of Reviewed Studies 
 
Table 1. Characteristics of Reviewed Studies 
      Use of PlasmaLyte versus Normal Saline for Preventing Hyperchloremic Acidosos in Fluid Resuscitation of DKA. 
 Quality Assessment 
Study 
 # 
Patients 
Design Limitations Inconsistency Indirectness Imprecision  Quality   (GRADE) 
Importance 
of 
Outcomes 
Notes 
NS PL 
Mahler et al 
23 26 
RCT no 
limitations 
none None no serious    
(-1) 
moderate  moderate End 
measurements 
taken post-
resuscitation 
Chua et al 14 9 Retrospective, 
non-
randomized, 
unblinded 
no 
limitations 
none None no serious   
( -1) 
very low  moderate Measurements 
taken at timed 
intervals over 
28 hours (2-4 h, 
4-6 h, 6-12 h, 
20-28 h) 
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Table 2. Summary of Change in Chloride and Bicarbonate Levels 
 
Table 2. Summary of Change in Chloride and Bicarbonate Levels      
              
Δ Chloride (mEq/L) NS IQR BES IQR 95% CI P value 
Mahler et al Post-Resuscitation 16.5       -- 8    -- 14-19 ≤ .001 
Chua et al 2-4 h 10   7 to 12 3  2 to 5 
 
<.01 
  4-6 h 13   7 to 23 3 -1 to 7 
 
<.01 
  6-12 h 18 10 to 29 5  1 to 11 
 
<.01 
  20-28 h 21 11 to 28 5 -2 to 11 
 
<.01 
Δ Bicarbonate (mEq/L)             
Mahler et al Post-Resuscitation 7 -- 9 -- 5-8 0.023 
Chua et al 2-4 h -0.03 -1.2 to 0.4 1.7 -0.2 to 4.2 
 
0.078 
  4-6 h 1.7 -0.1 to 5.9 8.4  5.4 to 9.4 
 
<.01 
  6-12 h 6.2   3.7 to 10.1 12.8  11.2 to 15.2 
 
<.05 
  20-28 h 10   8.2 to 12.9 16.6  11.9 to 18.1   0.16 
IQR = interquartile range 
NS = normal saline 
BES = Balanced Electrolyte Solution 
95% CI = 95% Confidence Interval 
 
